Old drug offers new hope of tailored pancreatic cancer treatment
A failed pancreatic cancer treatment could be resurrected as a personalised medicine aimed at one in five patients with the disease, research suggests.
Get unlimited access
As a subscriber you will benefit from:
- Full online and mobile access to news and opinion stories
Customised email alerts straight to your inbox (over 30 alerts available)
- 4,500 practice articles in our archive
- Over £500 worth of CPD learning units